In this article (Cancer Epidemiol Biomarkers Prev 2012;21:800–9), which was published in the May 2012 issue of Cancer Epidemiology, Biomarkers & Prevention (1), the authors regret a typographical error that appeared in Table 1. The value for "Breast conservation surgery" appeared as 7.707. The correct value is 7,707. A corrected table is shown below.
Table 1.
Characteristics . | All, N = 20,027 (%) . |
---|---|
Age, mean (y) | 72.2 |
Age group | |
65–69 years | 6,781 (33.9) |
70–74 years | 7,125 (33.6) |
75–79 years | 6,121 (30.6) |
AJCC stage | |
I | 11,506 (57.5) |
II | 7,203 (36.0) |
III | 1,318 (6.6) |
ER/PR status | |
Positive* | 13,798 (68.9) |
Negative | 2,502 (12.5) |
Both ER and PR unknown | 3,727 (18.6) |
Histologic grade | |
Poor | 5,018 (25.1) |
Moderate | 6,894 (34.4) |
Well | 2,827 (14.1) |
Unknown | 5,288 (26.4) |
First recurrence | |
0–5 years | 6,041 (30.2) |
0–10 years | 7,372 (36.8) |
Charlson Index score | |
0 | 17,179 (85.8) |
1 | 1,099 (5.5) |
2+ | 636 (3.2) |
Unknown | 1,113 (5.5) |
Surgery | |
Breast conservation surgery | 7,707 (38.5) |
Mastectomy | 10,551 (52.7) |
Non | 1,769 (8.8) |
Radiotherapy | |
Yes | 7,396 (36.9) |
No | 12,631 (63.1) |
Chemotherapy | |
Yes | 2,799 (14.0) |
No | 17,228 (86.0) |
Characteristics . | All, N = 20,027 (%) . |
---|---|
Age, mean (y) | 72.2 |
Age group | |
65–69 years | 6,781 (33.9) |
70–74 years | 7,125 (33.6) |
75–79 years | 6,121 (30.6) |
AJCC stage | |
I | 11,506 (57.5) |
II | 7,203 (36.0) |
III | 1,318 (6.6) |
ER/PR status | |
Positive* | 13,798 (68.9) |
Negative | 2,502 (12.5) |
Both ER and PR unknown | 3,727 (18.6) |
Histologic grade | |
Poor | 5,018 (25.1) |
Moderate | 6,894 (34.4) |
Well | 2,827 (14.1) |
Unknown | 5,288 (26.4) |
First recurrence | |
0–5 years | 6,041 (30.2) |
0–10 years | 7,372 (36.8) |
Charlson Index score | |
0 | 17,179 (85.8) |
1 | 1,099 (5.5) |
2+ | 636 (3.2) |
Unknown | 1,113 (5.5) |
Surgery | |
Breast conservation surgery | 7,707 (38.5) |
Mastectomy | 10,551 (52.7) |
Non | 1,769 (8.8) |
Radiotherapy | |
Yes | 7,396 (36.9) |
No | 12,631 (63.1) |
Chemotherapy | |
Yes | 2,799 (14.0) |
No | 17,228 (86.0) |
NOTE: ER+/no PR data, ER+/PR+, ER+/PR−, or ER−/PR+, or no ER data/PR+
References
1.
Cheng
L
, Swartz
MD
, Zhao
H
, Kapadia
AS
, Lai
D
, Rowan
PJ
, et al Hazard of recurrence among women after primary breast cancer treatment—a 10-year follow-up using data from SEER-Medicare
. Cancer Epidemiol Biomarkers Prev
2012
;21
:800
–9
.©2012 American Association for Cancer Research.
2012